OncoCyte (OCX) Misses Q1 EPS by 113c

OncoCyte (NASDAQ: OCX) reported Q1 EPS of ($1.13). Revenue for the quarter came in at $180 thousand.

For earnings history and earnings-related data on OncoCyte (OCX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• NVE Corporation names new CEO and expands board to seven members